Depletion of TM6SF2 disturbs membrane lipid composition and dynamics in HuH7 hepatoma cells. by Ruhanen, Hanna et al.
Contents lists available at ScienceDirect
BBA - Molecular and Cell Biology of Lipids
journal homepage: www.elsevier.com/locate/bbalip
Depletion of TM6SF2 disturbs membrane lipid composition and dynamics in
HuH7 hepatoma cells
Hanna Ruhanena,b, P.A. Nidhina Haridasa, Eeva-Liisa Eskelinenb, Ove Erikssonc,
Vesa M. Olkkonena,d, Reijo Käkeläb,⁎
a Minerva Foundation Institute for Medical Research, Biomedicum 2U, FI-00290 Helsinki, Finland
b Department of Biosciences, University of Helsinki, FI-00014 Helsinki, Finland
c Biochemistry and Developmental Biology, Academic Medical Center Helsinki, Faculty of Medicine, University of Helsinki, FI-00014 Helsinki, Finland
d Department of Anatomy, Academic Medical Center Helsinki, Faculty of Medicine, University of Helsinki, FI-00014 Helsinki, Finland








A B S T R A C T
A polymorphism of TM6SF2 associates with hepatic lipid accumulation and reduction of triacylglycerol (TAG)
secretion, but the function of the encoded protein has remained enigmatic. We studied the effect of stable
TM6SF2 knock-down on the lipid content and composition, mitochondrial fatty acid oxidation and organelle
structure of HuH7 hepatoma cells. Knock-down of TM6SF2 resulted in intracellular accumulation of TAGs,
cholesterol esters, phosphatidylcholine (PC) and phosphatidylethanolamine. In all of these lipid classes,
polyunsaturated lipid species were significantly reduced while saturated and monounsaturated species increased
their proportions. The PCs encountered relative and absolute arachidonic acid (AA, 20:4n-6) depletion, and AA
was also reduced in the total cellular fatty acid pool. Synthesis and turnover of the hepatocellular glycerolipids
was enhanced. The TM6SF2 knock-down cells secreted lipoprotein-like particles with a smaller diameter than in
the controls, and more lysosome/endosome structures appeared in the knock-down cells. The mitochondrial
capacity for palmitate oxidation was significantly reduced. These observations provide novel clues to TM6SF2
function and raise altered mebrane lipid composition and dynamics among the mechanism(s) by which the
protein deficiency disturbs hepatic TAG secretion.
1. Introduction
Non-alcoholic fatty liver disease (NAFLD) with a global prevelance
of 25 to 30% ranges from simple steatosis to non-alcoholic steatohepa-
titis (NASH) and cirrhosis, and can progress into hepatocellular
carcinoma [1]. Genetic variants of patatin-like phospholipase domain
containing 3, PNPLA3 (rs738409 and rs2281135), transmembrane 6
superfamily member 2, TM6SF2 (rs58542926) and membrane bound O-
acyltransferase domain containing 7, MBOAT7 (rs641738) are asso-
ciated with the development of NAFLD [2–4].
The allelic frequency of the TM6SF2 variant is 7% and the carriers
have increased susceptibility to NAFLD [3] but are protected from
cardiovascular diseases [5]. TM6SF2 is predominantly expressed in
liver, small intestine and kidney. It encodes a protein of 351 amino
acids with 7–10 predicted transmembrane domains. The variant
TM6SF2 encodes lysine instead of glutamine at position 167 of the
protein (Glu167Lys). This substitution decreases the stability of the
TM6SF2 protein [3]. TM6SF2 knock-down in mouse liver elevated the
levels of hepatic cholesterol and triacylglycerols (TAGs), while very-
low-density lipoprotein (VLDL) secretion was found to be reduced and
the animals displayed reduced plasma cholesterol and TAG concentra-
tions [3,5]. Consistently, hepatic TM6SF2 overexpression led to in-
creased levels of hepatic total cholesterol and plasma low-density
lipoprotein (LDL) cholesterol [6]. Recently, Smagris et al. [7] reported
that the decrease of plasma TAGs in TM6SF2 knock-out mice is not due
to reduced VLDL secretion but decreased lipidation of the VLDL
particles.
The TM6SF2 protein is localized in the endoplasmic reticulum (ER)
and the Golgi complex of hepatocytes [7,8], where the assembly and
lipidation of VLDL particles takes place. Thus, the observed instability
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of the variant TM6SF2 protein [3] may disturb the lipidation of VLDL
particles. The membrane contents of polyunsaturated fatty acids
(PUFAs), especially arachidonic acid (20:4n-6, AA), have recently been
implicated in efficient clustering of TAGs for lipoprotein transport [9].
However, in TM6SF2 knock-out mice no major differences were found
in the level of hepatic phosphatidylcholines (PCs) or in their fatty acid
(FA) composition [7]. The knock-out mouse model of Fan et al. [6]
rather implicated a predominant role of TM6SF2 in cholesterol
metabolism. Thus, the mechanism of TM6SF2 function is unknown
and the cause of increased hepatic lipid content in carriers of the
variant allele is not understood.
In this study, we analyzed in vitro the effect of TM6SF2 on
hepatocyte lipid content and lipid species composition using the human
hepatocyte cell line HuH7 subjected to knock-down of TM6SF2. Pulse
chase experiments with [13C]glycerol were performed to investigate the
turnover rates of different lipids. To investigate the functional con-
sequences of the lipid alterations, we studied the rates of mitochondrial
oxygen consumption (OCR) with FA as substrate, in the control and
TM6SF2 knock-down cells. In addition, electron and fluorescence
microscopy were employed to observe possible differences in organelle
structure or distribution between the TM6SF2 deficient and control
cells. The hallmark observations in the TM6SF2 knock-down cells were
an enrichment of saturated (SFAs) and monounsaturated FAs (MUFAs)
in storage and membrane lipids, a depletion of AA in PCs, and
functional changes indicated by a reduced mitochondrial OCR with
FA as substrate, an increase in the number of lysosome/endosome
structures as compared to controls, and reduced size of secreted
lipoprotein-like particles. These observations provide novel clues to
the TM6SF2 function and suggest that an altered membrane lipid
composition and dynamics play roles in the mechanism(s) by which the
protein deficiency disturbs hepatic TAG secretion.
2. Materials and methods
2.1. Cell culture and generation of HuH7 hepatocytes with TM6SF2 stably
knocked down
TM6SF2 knock-down HuH7 hepatocytes were generated using a
lentiviral transduction approach. Briefly, HuH7 cells were cultured in
MEM AQ™ (Minimal essential Eagle medium; Sigma-Aldrich, St. Louis,
MO) with 10% FBS (fetal bovine serum), 100 μg/ml streptomycin and
100 U/ml penicillin. Cells were grown to 70% confluency and trans-
duced with lentiviral particles encoding shRNA against TM6SF2
(TRCN0000254085, Sigma-Aldrich) or a non-targeting control
(SHC002V), according to the manufacturer's protocol. Transduced cells
were selected with puromycin (5 μg/ml). The selected cells were grown
further in the above medium containing puromycin and used for further
experiments. The experiments were performed using two independent
biological replicates.
2.2. Gene expression analysis (qPCR)
Expression of TM6SF2 gene was analyzed by quantitative polymer-
ase chain reaction (qPCR) by using Light Cycler 480 II (Roche Applied
Science, Penzberg, Germany). Total RNA was extracted from the
TM6SF2 knock-down and control HuH7 cells using PureLink® RNA
Mini Kit according to the manufacturer's protocol. cDNA synthesis was
carried out using SuperScript® VILO™ reverse transcriptase kit
(Invitrogen, Carlsbad, CA). Quantitative real time PCR was performed
with gene-specific primers (Table S1) and Roche SYBR-Green® master
mix. SDHA (Succinate dehydrogenase complex, subunit A) and β-actin
were used as housekeeping references, and the data were normalized to
a geometric mean of these.
2.3. Lipid labeling and analysis by mass spectrometry and gas
chromatography
For lipidomics, HuH7 cells cultured on 6-well plates as specified
above were washed with PBS and scraped into 1 ml of ice-cold 0.25 M
sucrose. For analysis of lipid turnover, the medium of the cells on 6-well
plates was on the day one after plating changed to a labeling medium
containing 500 μg/ml of [13C]glycerol (Cambridge Isotope
Laboratories, Andover, MA). The cells were first incubated for 24 h
and then chased for another 24 h in medium containing 5 mg/ml of
unlabeled glycerol.
Cellular lipids were extracted according to Folch et al. [10] and
dissolved in chloroform/methanol 1:2 (by vol). Just before mass
spectrometry, 1% NH4OH was added along with a cocktail of internal
lipid standards containing respresentatives for all lipid classes analyzed.
The samples were injected into the electrospray source of a triple
quadrupole mass spectrometer (Agilent 6490 Triple Quad LC/MS with
iFunnel Technology; Agilent Technologies, Santa Clara, CA) at a flow
rate of 10 μl/min, and spectra were recorded using both positive and
negative ionization mode. TAGs were detected as (M + NH4)+ ions
[11] and cholesterol esters (CEs) using precursor ion scanning of m/z
369 (P369) in the positive ion mode [12]. Phospholipid species were
selectively detected using head-group specific MS/MS scanning modes
(PC: P184, PE: neutral loss of 141 (NL141), PI: P241) [13]. The
unlabeled [M] and [13C]glycerol-labeled [M+ 3] ions were resolved
by comparing the spectra of cell samples with or without labeling, and
deconvolution into different species was performed by the best profile
fitting available in LIMSA software [14]. FA composition of total lipids
was determined by gas chromatography (quantitation by Shimadzu GC-
2010 Plus equipment with flame-ionization detector, GC-FID, and
identification of FA structures by Shimadzu GCMSQP2010 Ultra with
mass selective detector, GC-MSD) using procedures detailed in Käkelä
et al. [15]. In order to confirm the glycerolipid acyl chain assembly,
precursor scans for the main acyl chains, first detected by GC, were
recorded by ESI-MS/MS using negative mode precursor scans for the
acyl fragments released from PEs and PC formate adducts. The acyl
chains of the TAGs were verified by positive mode ESI-MS/MS using
acyl chain specific NL scans. Mass spectra were processed by Mas-
sHunter software (Agilent Technologies, Inc. California, USA) and
individual lipid species were quantified using the internal standards
and LIMSA software.
2.4. Analysis of de novo lipogenesis
HuH7 control and TM6SF2 knock-down cells were grown on 6-well
plates to confluency. Cells were then incubated with [3H]-Acetic acid
(150 μCi/well; Amersham, GE Healthcare) in complete media for 3 h.
Cells were washed and scraped in 2% sodium chloride. Total lipids were
extracted according to Bligh and Dyer [16]. The samples were run on
thin layer silica based chromatography using hexane/diethyl ether/
acetic acid/H2O (65:15:1:0.25,vol/vol) as the solvent system. TAG and
CE standards were run on TLC along with the samples to identify the
corresponding species. TAG and CE bands were scraped, the [3H]
radioactivity was measured by liquid scintillation counting, and the
results normalized for total cell protein.
2.5. Glucose uptake assay
Glucose uptake assay was done in HuH7 control and TM6SF2 knock-
down cells, which were starved in serum free, glucose free DMEM
(A14430-01, Thermo Scientific) for one hour, after which glucose
uptake was initiated by the addition of 0.5 ml DMEM with 100 μM
cold D-glucose and 0.1 μCi of deoxy-D-glucose 2-[1,2-3H (N)] (Perkin
Elmer). The uptake was terminated by removing the media and adding
ice cold PBS. The cells were washed and then lysed with 0.1% sodium
dodecyl sulfate (SDS). The radioactivity in the cells was measured by
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liquid scintillation counting. The radioactive counts were normalized to
total protein.
2.6. Glycogen synthesis assay
HuH7 control and TM6SF2 knock-down cells were grown on 6-well
plates to confluency. The cells were starved overnight in DMEM
(D5546, Sigma-Aldrich) containing 0.5% BSA and 2 mM L-glutamine.
Next day the cells were incubated in 0.18 μCi/μmol D- [U-14C]-glucose
(PerkinElmer) for 1 or 4 h, washed with ice cold PBS and frozen
overnight in −20 °C. Samples were lysed in 0.7 ml 0.03% SDS and
0.4 ml of the suspension was transferred to 2 ml tubes together with
1 mg carrier glycogen. The remaining cell suspension was used for
protein concentration determination by the bicinchoninic acid (BCA)
assay (Thermo Scientific, Waltham, MA). The original samples were
heated in 100 °C for 30 min. Glycogen was precipitated by addition of
99% ethanol and incubated overnight in−20 °C. Glycogen pellets were
collected by centrifugation for 15 min at 10000 rpm, washed once with
70% ethanol and resuspended in 200 ml distilled water. Radioactivity
was determined by liquid scintillation counting. Each experiment was
carried out on triplicate wells.
2.7. Analysis of mitocondrial oxygen consumption rate (OCR)
The OCR of control and TM6SF2 knock-down cells was measured
using the Seahorse XF96 Extracellular Flux Analyzer (Agilent
Technologies). Both control and TM6SF2 knock-down HuH7 cells were
plated onto Poly-L-Lysine coated XF96 cell culture micro plates (Agilent
Technologies). Cells were grown until confluency in growth medium,
followed by a serum starvation for 4 h in XF base medium (Agilent
Technologies) supplemented with 0.5 mM glucose, 1 mM glutamine
and 0.5 mM carnitine. Cells were then moved to a CO2 free incubator
and incubated for another 1 h in XF base medium supplemented with
0.5 mM glucose and 0.5 mM carnitine, after which cells were treated
with 0.17 mM FA free BSA or 0.16 mM palmitic acid (Sigma–Aldrich)
conjugated with FA free BSA, and incubated for an additional 1 h. The
OCR was measured using the XF Cell Mito Stress Test Kit (Agilent
Technologies) with following additions: oligomycin (0.6 μM), FCCP
(0.5 μM), and rotenone (0.5 μM) plus antimycin A (0.5 μM). Three 3-
min cycles were measured for each condition and the OCR were
normalized to total protein content of each well determined by the
BCA assay. The basal respiration due to utilization of exogenous FAs
was calculated according to the manufacturer's protocol (basal palmi-
tate-BSA rate minus basal BSA rate minus OCR due to uncoupling by
free FAs).
2.8. Electron microscopy (EM) of cells
The cells were grown on glass cover slips for flat embedding, while
normal cell culture dishes were used for pellet embedding. For flat
embedding, the cells were fixed in 2% glutaraldehyde in 0.1 M
cacodylate buffer, pH 7.4, for 30 min at room temperature. For pellet-
ing, cells were fixed in 2% glutaraldehyde in 0.2 M Hepes, pH 7.4, at
room temperature for 2 h. The cells were then scraped off the dish after
30-min fixation, pelleted with a microcentrifuge in the fixative, and the
fixation was continued as a pellet. The fixed cells and cell pellets were
then washed, post-fixed in 1% osmium tetroxide, dehydrated in ethanol
and acetone, and embedded in TAAB resin. Thin sections were cut using
a diamond knife and stained with uranyl acetate and lead citrate.
Pelleted cells were used for quantification of cytoplasmic volume
fractions due to the random orientation of cells in relation to the section
plane in such specimens. Micrographs were taken using uniform
random sampling at 2000× primary magnification, using a Jeol
JEM-1400 transmission electron microscope. A total of 65–70 micro-
graphs for each sample were used for the quantification. The area of the
cytoplasm and the organelles was quantified using point counting as
detailed in [17]. The ratio of the organelle area per cytoplasmic area
was used as an estimate for the volume fraction.
2.9. Immunofluorescence microscopy
TM6SF2 knock-down and control HuH7 cells on coverslips were
fixed with 4% paraformaldehyde in PBS and permeabilised using 0.1%
Triton X-100. Cells were then washed twice with PBS and unspecific
antibody binding was blocked with 10% FBS, followed by incubation
with anti-LAMP1 (H4A3, Santa Cruz biotechnology) for 2 h at room
temperature. Cells were then washed thrice using PBS and incubated
with Alexa Fluor®488- Anti-mouse (A11001, Invitrogen Life Sciences).
After washing thrice the coverslips were mounted using Mowiol
(Calbiochem, La Jolla, CA) containing 50 mg/ml 1,4-Diazabicyclo-
[2.2.2] octane (Sigma–Aldrich) and 5 μg/ml DAPI (Thermo Scientific/
Molecular Probes). Cells were imaged using Zeiss Axio Observer Z1
microscope (Carl Zeiss Imaging Solutions GmbH, Oberkochen,
Germany) with an objective of 63× magnification and numerical
aperture 1.4 and Colibri laser and with same exposure time for both
control and knock-down cells. LAMP1 stainings were quantified using
FIJI (Image J) software with a set cutoff threshold (total signal
intensity/number of cells in the field). Approximately 100 cells were
measured in both TM6SF2 knock-down and control specimens.
2.10. EM of secreted lipoprotein-like particles
HuH7 control and TM6SF2 knock-down cells were grown in 75 cm3
flasks to confluency, after which media samples were collected and
concentrated using Spectra/Por® 4 dialysis tubing (Spectrum
Laboratories, Inc., California, USA) against crystal sucrose and then
dialyzed against PBS. The samples were centrifuged, pipetted on
formwar-coated, glow discharged grids and negative stained using 1%
phosphotungstic acid. Micrographs were taken using a Jeol JEM-1400
transmission electron microscope. Electron micrographs were processed
using ImageJ open platform image processing program to analyze
secreted particles. A median filter was first applied using a kernel of a
radius of 5-pixels, then the images were automatically thresholded
using the percentile method. Thresholded images were used to detect
regions with an area between 1000 and 3000 pixels square and a
circularity value of at least 0.3. This method allowed reliable automated
detection of secreted particles within the defined range. The Pixel value
was converted to nm2 and the diameter of the particles were calculated.
2.11. Quantification of apolipoprotein B100 secretion
HuH7 control and TM6SF2 knock-down cells grown on 12-well
plates were kept overnight in MEM AQTM containing 100 μg/ml
streptomycin and 100 U/ml penicillin, and the following day the media
were collected, centrifuged and stored at −20 °C. The cells were lysed
and used for protein concentration determination by the BCA assay. The
media were analyzed using Human Apolipoprotein B ELISAPRO kit
(3715-1HP-2, Mabtech, Sweden) according to the manufacturer's pro-
tocol. The absorbance was measured at 450 nm in a microplate reader
and a 4-parameter curve fitting program was used for data analysis.
2.12. Statistical analysis
For univariate comparisons statistical significance was determined
by a two-tailed Student's t-test. For multivariate comparisons of detailed
lipid profiles, Principal Component Analysis (PCA) (Sirius, PRS, Bergen,
Norway) was used. The PCA shows compositional differences between
the samples, and highlights the lipid species mainly responsible for the
variation in the data. For PCA, arcsine transformed data were used and
the relative positions of the samples and variables were plotted using
the first two principal components. The differences between the groups
seen in the PCA were further quantitatively analyzed using Soft
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Independent Modeling of Class Analogy (SIMCA; Sirius) [18].
3. Results
3.1. Triacylglycerol and cholesterol ester concentrations are increased in
HuH7 hepatocytes with TM6SF2 stably knocked down
HuH7 cells were subjected to stable knock-down of TM6SF2 using a
shRNA expressing lentivirus. To avoid biases caused by phenotypic
aberrations frequently occurring in single-cell clones, pools of trans-
duced cells were analyzed. In such pools, an average knock-down
efficiency of 60% at the mRNA level was observed as compared to
controls transduced with a non-targeting shRNA lentivirus (Fig. 1A).
Upon mass spectrometric analysis of the cellular lipids, significant
elevations of total TAG (32%) and CE (41%) concentrations were
observed in the TM6SF2 knock-down cells (Fig. 1B–C), consistent with
previously published reports [3,8].
3.2. TM6SF2 silenced cells are relatively depleted of PUFA containing lipids
and enriched in SFA and MUFA containing lipids
Lipid species profiles of the control and TM6SF2 knock-down cells
were subjected to PCA to reveal lipidome differences between the cell
pools (Fig. 2A–D) (The full lipid species data are shown in Tables S2–6).
The most important principal component PC1 (horizontal axes) repre-
sented the degree of unsaturation of the lipid species, and explained
60% (TAG), 64% (CE), 88% (PC) or 93% (PE) of the variation in the
lipid classes displayed (Fig. 2A–D). When focusing on TAG composition,
the control cells grouped on the left-hand side of the PCA biplot i.e. they
contained more TAGs with PUFA moieties (e.g. TAG species 56:6, 56:7,
58:7, and 58:8) whereas the TM6SF2 knock-down cells grouped on the
right-hand side, and were characterized by TAGs with SFAs and MUFAs
(Fig. 2A). The difference in the TAG species profiles of the control and
TM6SF2 knock-down was significant according to SIMCA (p < 0.05).
When CE species were used as loadings, PCA indicated a similar loss
of unsaturated acyl chains in TM6SF2 knock-down cells as was found
for the TAGs (Fig. 2B). The most divergent CE species variable, located
furthest from the origin, was CE 22:6 (CE with docosahexaenoic acid, or
DHA, moiety). In general, TM6SF2 knock-down cells (5 out of 6
replicates) contained smaller relative amounts of CE 22:6 and at the
same time more of SFA and MUFA containing CEs as compared to the
controls.
For the major membrane phospholipids of the cells, PCs and PEs, the
PCA separation by PC1 (acyl chain unsaturation) was very clear
(Fig. 2C–D) and quantitatively significant (SIMCA, p < 0.05). Of note,
this change in the PC and PE species composition was accompanied by
an increase in the total level of cellular PCs and PEs in the TM6SF2
knock-down cells as compared to controls (inserts, Fig. 2C–D). Similar
to the TAGs and CEs, the TM6SF2 knock-down cells contained higher
relative amounts of PC and PE species carrying SFAs and MUFAs and
less species with PUFA chains, especially AA (e.g. 36:4, 38:4, and 38:5,
the presence of AA verified upon fragmentation by ESI-MS/MS). This
suggests that there is a global shift in the lipid species profile of the
TM6SF2 knock-down cells. Furthermore, when the FA composition in
the total lipids of the cells after 24 h culture was investigated by gas
chromatography, the total level of AA was found to be significantly
lower (p < 0.01) in the TM6SF2 knock-down cells as compared to
controls (Table S7).
3.3. Absolute levels of AA containing PCs are decreased in TM6SF2 knock-
down cells
In order to clarify whether the changes observed in the phospholipid
species composition of the TM6SF2 knock-down cells were due to
increase in the levels of SFA/MUFAs containing species or decrease of
PUFA (especially AA) containing species, or possibly both, we calcu-
lated the absolute levels of these lipids by normalizing them to total
cellular protein. In PCs, but not in any other phospholipid class
analyzed (PEs and PIs), the absolute levels of AA containing species
36:4 and 38:5 were in 24-h cultures significantly lower in TM6SF2
knock-down cells as compared to controls (Fig. 3A). After extended
(one week) culture time also the difference in PC 38:4 became
significant (Fig. 3B). When looking at the levels of SFA/MUFA contain-
ing lipids, significant increases in the absolute levels of PC 34:2, 36:1
and 36:2 at the 24-h time point and PC 34:1, 36:1 and 36:2 at the one
week time point were observed in the TM6SF2 knock-down cells as
compared to controls (Fig. 3A–B). Comparison of the 24-h and one
week culture times revealed that, overall, the differences in the lipid
levels between the cell pools became more pronounced over the time.
3.4. Glycerolipid turnover is enhanced in TM6SF2 knock-down cells
[13C]glycerol labeling was employed to study the synthesis and
turnover of glycerolipids in the TM6SF2 knock-down cell model.
Significantly higher total levels of [13C]glycerol labeled TAGs, PCs,
PEs, and PIs accumulated in the TM6SF2 knock-down cells as compared
to controls during 24 h (Fig. 4A–D). However, during 24-h chase in a
medium containing unlabeled glycerol, the amount of the labeled lipids
also reduced more rapidly in the TM6SF2 knock-down cells as
compared to controls (turnover rates are indicated by the slopes
visualized in the panels of Fig. 4). Consistent with the enhanced
incorporation of [13C]glycerol into TAGs, we also observed an elevation
Fig. 1. Knocking down TM6SF2 increases TAG and CE levels in HuH7 cells. (A) TM6SF2 mRNA expression levels analyzed by qPCR. TM6SF2 was stably knocked down using lentiviral
particles encoding shRNA against TM6SF2 (shTM6SF2); control (Ctrl) cells were transduced with a non-targeting shRNA encoding virus (n = 3). (B-C) Total quantity of TAGs and CEs
after 24-h culture, analyzed by ESI-MS/MS. The values represent mean ± SD (n = 6); * p < 0.05, *** p < 0.001.
H. Ruhanen et al. BBA - Molecular and Cell Biology of Lipids 1862 (2017) 676–685
679
of [3H]acetic acid incorporation into TAGs and CEs during a 3-h
labeling, as a measure of de novo lipogenesis (Fig. S1). However,
glucose uptake or glycogen synthesis were not affected (Fig. S2).
3.5. TM6SF2 knock-down cells secrete smaller lipoprotein-like particles
We next wanted to see if changes in the lipid profile of the cells
associate with an altered secretion of lipoproteins. We performed EM of
particles secreted into growth media of control and TM6SF2 knock-
down cells. While large, spherical lipoprotein-like particles were
prominently present in the medium of control cells, the size of the
particles secreted by TM6SF2 knock-down cells was markedly smaller
(Fig. 5A). The relative particle size distribution of the cells (Fig. 5B)
revealed that particles> 20 nm in diameter were nearly undetectable
in the medium of TM6SF2 knock-down cells. However, apolipoprotein
B100 secretion was not reduced but rather slightly increased in the
TM6SF2 knock-down cells (Fig. 5C).
3.6. TM6SF2 knock-down cells display a reduced rate of mitochondrial
fatty acid oxidation
Mitochondrial β-oxidation was measured by the mitochondrial
oxygen consumption rate (OCR) in TM6SF2 knock-down and control
cells, using palmitic acid (16:0) as substrate. The result of a mitochon-
drial stress test experiment carried out with the Seahorse® metabolic
flux analyzer is presented in Fig. 6. The measurements showed that the
basal OCR in the presence of palmitic acid was higher in control cells
than in the TM6SF2 knock-down cells (Fig. 6A–B). Both TM6SF2 knock-
down and control cells responded to the addition of the ATP-synthase
inhibitor oligomycin by a decrease in the OCR (Fig. 6A). Subsequent
addition of the uncoupler FCCP lead to a rapid activation of the OCR in
both TM6SF2 knock-down and control cells (Fig. 6A). These finding
indicate that TM6SF2 knock-down lead to a decreased basal OCR, while
the mechanisms coupling ATP production to oxygen consumption
remained unaffected, suggesting that TM6SF2 knock-down selectively
acted on some component(s) required for β-oxidation. Quantitative
analysis yielded that TM6SF2 knock-down lead to a 63% drop in the
basal palmitate-driven OCR, compared to control cells (Fig. 6B).
Fig. 2. Principal component analysis (PCA) of the effect of TM6SF2 knock-down on the lipid profile of HuH7 cells. TM6SF2 knock-down and control cells were cultured for 24 h, the lipid
species analyzed as described in Material and Methods, and the data subjected to PCA. The samples located furthest from the origin of the PCA biplot (marked as +) on one side contain
relatively more of the lipid species furthest on that same side. The longer the distance between two samples on the plot the more their lipid profiles differ from each other. Arrows show
the direction of the Principal Components 1 and 2 (PC1 and PC2) and the percentages represent the proportion of the variation in the data each PC axis explains. (A) PCA of TAG species.
Lipid species present at> 0.5% were used as variables. The species are identified as ‘number of carbons’:’number of double bonds' in the acyl chains. C, control; T, shTM6SF2. (B) PCA of
CEs. All analyzed species were used as variables. (C) PCA of PCs. Species present at> 0.5% were used as variables. a = alkyl-acyl species. (D) PCA of PEs. All analyzed lipids were used as
variables. Total quantities of PCs and PEs are shown in the inserts. Values in the inserts represent mean ± SD (n = 6); * p < 0.05, ** p < 0.01.
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Fig. 3. Knocking down TM6SF2 increases levels of PCs with SFA and MUFA moieties and decreases levels of AA (20:4n-6)-containing PCs. Quantities of the major PC species with SFA,
MUFA and AA moieties analyzed by ESI-MS/MS after culturing the cells for 24 h (A) or one week (B) are shown. The values represent mean ± SD (n= 6); * p < 0.05, ** p < 0.01, ***
p < 0.001.
Fig. 4. Glycerolipid turnover is enhanced in TM6SF2 knock-down hepatocytes. Total quantity of [13C]glycerol labeled TAGs (A), PCs (B), PEs (C) and PIs (D) after 24-h labeling and 24-h
chase, analyzed by ESI-MS/MS, are shown. Turnover rates are indicated by the slopes in the panels. The values represent mean ± SD (n = 6); *** p < 0.001.
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3.7. Expansion of late endosome/lysosome structures in TM6SF2 knock-
down hepatocytes
A significant increase in the absolute cellular concentrations (per
total cell protein) of the major classes of membrane phospholipids, PCs
and PEs, was observed in the TM6SF2 knock-down hepatocytes (see
Fig. 2C–D). We therefore carried out EM in order to detect possible
differences in organelle structure of the cells. An increased number of
late endosomes/lysosomes was evident in the sections of TM6SF2
knock-down cells as compared to controls. Quantification of the volume
fraction of late endosomes/lysosomes in the cytoplasmic compartment
of these cells revealed a 2.9-fold increase relative to the controls
(Fig. 7A). To further confirm this observation, we performed immuno-
fluorescence microscopy with antibodies against the lysosome marker
LAMP1. The LAMP1 staining intensity was 2-fold higher in the TM6SF2
knock-down cells than in the controls (Fig. 7B), consistent with an
Fig. 5. TM6SF2 knock-down hepatocytes secrete smaller lipoprotein-like particles into growth medium. (A) Electron microscopy images of secreted particles after negative staining of the
media samples. (B) Relative size distribution of the secreted particles (the number of quantified particles: Ctrl, 813; shTM6SF2, 651). (C) Apolipoprotein B100 secretion measured by
ELISA and normalized for total cellular protein. The values represent mean ± SD (n = 17); *** p < 0.001.
Fig. 6. Oxygen consumption rate (OCR) in the presence of palmitic acid is reduced in TM6SF2 knock-down hepatocytes. ORC was measured in real-time using the Seahorse® metabolic
flux analyzer as described in Materials and Methods. (A) The OCR curves; the times of addition of oligomycin, FCCP, and rotenone + antimycin A are indicated at the top. OCR in the
presence of palmitate-BSA (PA) and BSA are displayed. (B) Basal OCR due to utilization of exogenous fatty acids. The values represent mean ± SD (n = 7–10); ** p < 0.01.
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amplification of the late endosomal/lysosomal compartments.
4. Discussion
TM6SF2 is a novel key regulator of hepatic VLDL TAG secretion. Its
common sequence variant reducing the stability of the encoded protein
[3] associates with hepatic TAG accumulation but acts protective
against cardiovascular diseases [5,19]. However, the molecular me-
chanisms of TM6SF2 function have remained enigmatic. In the present
study we knocked down TM6SF2 by 60% in the human HuH7 hepatoma
cell line, which has been employed in previous investigations as a
hepatocyte model to assess the function of TM6SF2 [3,8]. Mass
spectrometric analysis of the cellular lipidome and its dynamics,
measurements of mitochondrial oxygen consumption rate and studies
of organelle structure revealed that TM6SF2 knock-down results in (i)
Accumulation of TAGs and CEs in the cells, (ii) Relative enrichment of
SFAs/MUFAs in all major lipid classes, (iii) Absolute increase of PCs and
PEs with SFAs and MUFAs, (iv) Relative and absolute depletion of AA
from PCs, (v) Enhanced synthesis and turnover of the hepatocellular
membrane and storage lipids, (vi) Modification of the total cellular FA
pool, with SFAs/MUFAs increased and AA reduced, (vii) Reduction in
the size of secreted lipoprotein-like particles, (viii) Defect in mitochon-
drial OCR in the presence of a FA substrate, and finally (ix) Increase of
the volume of late endosomal/lysosomal compartments. Depletion of
TM6SF2 thus has extensive, global effects on hepatocellular lipid
metabolism.
It is becoming evident that the hepatic lipid composition plays a
major role in lipoprotein secretion, lipid accumulation and pathology.
The excess SFAs and MUFAs found in this work in the TM6SF2 knock-
down cells, have been reported to have deleterious effects on liver
function and cause tissue damage [20]. In our cell model, the
accumulation of SFAs and MUFAs could be due to the elevated de novo
lipogenesis utilizing these acyl chains, or occur through other mechan-
isms such as enhanced SCD1 activity in the knock-down cells. Stearoyl
desaturase 1 (SCD1, Δ-9 desaturase) activity was found to increase in
fatty liver diseases, leading to the accumulation of MUFAs [21], and
inhibition of SCD1 reduced the induction of hepatic steatosis in mouse
models [22]. On the other hand, increased SCD1 activity was also
suggested to have a protective effect against hepatic injury. SCD1
converts SFAs to MUFAs, enhances the incorporation of MUFAs to
TAGs, and protects the liver from the lipotoxicity of SFAs [23]. Similar
to the TM6SF2 knock-down cells, the hepatic PUFA levels of NASH
patients were found to be low and the degree of PUFA reduction was
reported to correlate with disease severity [24]. In addition, a variant of
FA desaturase 1 (FADS1, Δ-5 desaturase), impairing the insertion of the
last double bond when producing AA, has been associated with hepatic
lipid accumulation [25]. Moreover, cells and mice deficient in lysopho-
sphatidylcholine acyltransferase 3 (LPCAT3) had reduced levels of AA
in their membrane phospholipids, PCs in particular, resulting in
defective lipoprotein secretion [9,26]. Thus aberrations of different
proteins modifying or transferring FAs may drive the hepatic lipid
accumulation.
The hepatocyte TM6SF2 protein has been localized to the ER and
the Golgi apparatus [7,8], key organelles of the secretory pathway
responsible for the assembly and secretion of VLDL [27,28]. It is thus
plausible that this gene product may modify the lipid composition of
the secretory pathway membranes in a manner that promotes their
compatibility with lipoprotein production. Thus the reduction of PCs
with AA in our TM6SF2 knock-down cells is an especially interesting
finding and may represent a key to the observed cellular neutral lipid
accumulation. In mice, a similar reduction of AA in membrane
phospholipids due to LPCAT3 deficiency caused a marked reduction
of plasma VLDL-TAGs with concomitant hepatic steatosis [26], a
phenotype reminiscent of that observed in TM6SF2 knock-out mice
[7]. Consistent with the study of Smagris et al. [7], we also observed a
reduction in the size distribution of lipoprotein-like particles secreted
by the TM6SF2 knock-down cells, while production of apoB100 was not
defective.
Fig. 7. Amplification of late endosome/lysosome structures in TM6SF2 knock-down hepatocytes. (A) Electron microscopy images showing more lysosome/late endosome structures in
TM6SF2 knock-down cells (shTM6SF2) as compared to controls. The quantifications represented are from 60 to 70 micrographs. (B) Lamp1 staining of control and TM6SF2 knock-down
cells and its quantification (from 100 to 120 cells). The values represent mean ± SEM, ** p < 0.01, *** p < 0.001.
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Besides impaired lipoprotein secretion, the increased lipid content
of liver tissue or cultured hepatocytes upon TM6SF2 knock-down or
knock-out [3,5,7,8] may in principle reflect enhanced hepatic FA
uptake or de novo lipogenesis, reduced mitochondrial oxidation of
FAs, or a defect of glucose metabolism and storage as glycogen. We
observed in the TM6SF2 knock-down hepatocytes enhanced de novo
lipogenesis and reduced FA oxidation. However, no significant altera-
tion of glucose uptake or glycogen synthesis was detected (Fig. S2),
pointing to a primary function of TM6SF2 in lipid metabolism.
Labeling/chase of lipids with [13C]glycerol revealed both enhanced
lipid synthesis and turnover in the TM6SF2 knock-down cells. If the
balance of these counteracting homeostatic distortions is biased to-
wards increased synthesis, as indicated by the enhanced de novo
lipogenesis observed, this could be one plausible cause of the lipid
accumulation observed in the TM6SF2 depleted cells. On the other
hand, the fact that also the lipid turnover was increased in the TM6SF2
knock-down cells may explain why the TAG accumulation in our model
was not dramatic. The reason for the enhanced dynamics of lipid
synthesis/turnover is so far unknown. One possible mechanistic ex-
planation to the increased de novo lipogenesis is ER stress caused by
TAG accumulation. TM6SF2 deficiency has been reported to result in
ER stress [29], which is known to induce several signaling pathways up-
regulating hepatic lipogenesis [30]. One is also tempted to speculate
that a distortion of the FA composition of phospholipids (i.e. reduction
of PUFAs, AA in particular), may trigger a futile cellular response aimed
at maintaining an optimal composition of membrane lipids via en-
hanced phospholipid synthesis, at the end manifested in the excess of
storage lipids as well. In addition to TM6SF2, deficient variants of
PNPLA3, MBOAT7 and MBOAT5, which recently were implicated in
acyl-chain remodeling of lipids, also induce fatty liver [26,31,32]. Thus,
a possible role of TM6SF2 in incorporating AA and other PUFAs into
membrane phospholipids should be studied further.
Impaired FA oxidation and ultrastructural changes in mitochondria
have been reported as causes of mitochondrial dysfunction in NAFLD
[33,34]. Therefore, we considered mitochondrial dysfunction as one
tentative reason for the lipid accumulation in the TM6SF2 silenced
cells. The present observations indeed suggest impaired mitochondrial
FA oxidation in these cells. Thus, besides defective TAG secretion and a
tentative dysbalance in lipid synthesis/turnover, reduced mitochondrial
FA oxidation may be a putative cause of the cellular accumulation of
TAGs, CEs, PCs and PEs in the present cell model. Of note, only hepatic
TAG and CE but not phospholipid accumulation was previously
detected in the TM6SF2 knock-out mice [7], reflecting an obvious
difference between the in vivo and in vitro models or a species
difference. The mechanism through which TM6SF2 deficiency might
impair mitochondrial function remains subject of future study. In
addition, any direct mechanistic link between deficient mitochondrial
FA oxidation and enhanced de novo lipogenesis cannot yet be proposed.
However, a similar situation was observed in hepatocytes from mice
deficient in BNip3 [35]. In those cells, impaired mitochondrial β-
oxidation was associated with de novo lipogenesis utilizing glucose-
derived acetyl-CoA.
While the TAGs and CEs stored in cellular lipid droplets are the
frequent response for improved lipogenesis or impaired utilization of
lipids, the increased absolute quantities of cellular PCs and PEs found in
the TM6SF2 knock-down cells formed an intriguing question. To obtain
clues of the fate of these lipids, we carried out transmission EM, which
revealed a markedly elevated volume of lysosomal compartments in the
TM6SF2 knock-down cells. EM observation of TM6SF2-deficient hepa-
tocytes or liver tissue has not been reported previously. Thus, this
observation is novel. It may reflect a homeostatic response triggered in
order to hydrolyze an excess of membranes that harbor the accumulat-
ing phospholipids. However, the amplification of lysosomes may
equally well represent a cellular metabolic adaptation unrelated to
the cellular phospholipid excess.
Together with human studies such as that of Luukkonen et al. [36]
on the role of hepatic ceramides in NAFLD, our work supports a
lipocentric view to liver disease. One can envision that subjects carrying
variants of genes such as TM6SF2 or MBOAT7 [3,32] might benefit
from dietary supplementation with PUFAs. On the other hand, prevent-
ing CVD by depressing TM6SF2 function [5] might lead to a risk of
developing liver disease; therefore, such therapeutic strategies should
be considered with caution.
TM6SF2 knock-down in human HuH7 hepatoma cells resulted in the
enrichment of SFAs/MUFAs in several lipid classes, depletion of PCs
with AA, reduced mitochondrial FA oxidation and amplification of late
endosomal/lysosomal membrane compartment. Under normal condi-
tions, a dynamic PUFA-enriched ER membrane domain allows the
efficient synthesis of apoB-lipoprotein particles, and hepatocellular
lipid homeostasis is maintained. Upon TM6SF2 depletion, phospholi-
pids with SFAs and MUFAs accumulate and PUFAs are reduced,
resulting in a defect of assembly of apoB lipoproteins with a normal
size and lipid composition, associated with cellular neutral lipid
accumulation, reduced FA oxidation and an enlarged lysosomal com-
partment (see Graphical Abstract). The mitochondrial FA oxidation
defect could be due to (i) an unoptimal composition of the mitochon-
drial membranes, (ii) altered ER membrane structure decreasing the
size of the secreted lipid particles and possibly impairing the FA flux to
mitochondria, and finally (iii) altered structure of the ER membranes
disturbing the ER-mitochondial contacts and thereby the flux of FA and
also importantly the flux of Ca2+ between the organelles [37]. Further
functional studies are warranted to distinguish between the mechan-
isms hypothesized above.
To conclude, the present observations provide novel clues to the
function of TM6SF2 and the mechanism(s) by which the deficiency of
the protein disturbs hepatic lipoprotein mediated TAG secretion.
Specifically they suggest that the impaired secretion is associated with
distorted dynamics of membrane phospholipid synthesis/degradation
affected by the unoptimal phospholipid FA composition.
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